China FIC Drug

Drug Name: Onradivir  Drug Modality: Small Molecule Drug Target:  Influenza A virus RNA Polymerase PB2 Inhibitor Developed By：Guangdong Raynovent Biotech … [China FIC Drug] Influenza A virus RNA Polymerase PB2 Inhibitor First in Class Drug Onradivir Approved by China NMPA in 2025Read more

Drug Name: Dorzagliatin Drug Modality: Small Molecule Drug Target:  GKA (Glucokinase Activator ) Developed By：Hua Medicine Approved Date: … [China FIC Drug] Global First In Class Glucokinase Activator Dorzagliatin (Oral Antidiabetic Drug) Approved by China NMPA in 2022Read more